| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |